Literature DB >> 18161927

PlexinA1 expression in gastric carcinoma and its relationship with tumor angiogenesis and proliferation.

Xiang-Yang Zhao1, Lin Chen, Yu-Hong Li, Qian Xu.   

Abstract

AIM: To explore the expression of PlexinA1 in gastric carcinoma and its relationship with tumor angiogenesis and proliferation.
METHODS: PlexinA1 mRNA and protein expressions of Semaphorin6D were measured using semi-quantity reverse transcription PCR and Western blotting in 20 cases of gastric carcinoma and corresponding normal gastric mucosa. PlexinA1, Ki-67 expression and microvessel density (MVD) were detected by immunohistochemistry in 50 cases of gastric carcinoma and 20 cases of normal gastric mucosa.
RESULTS: The mRNA and protein expressions of PlexinA1 in gastric carcinoma were significantly higher than that in normal gastric mucosa (0.71 +/- 0.37 vs 0.60 +/- 0.25, P = 0.0299 < 0.05, and 0.47 +/- 0.16 vs 0.21 +/- 0.08, P = 0.0000 < 0.01), and MVD within tumor tissues increased significantly with PlexinA1 mRNA expression (r =0.8736, P < 0.01) and PlexinA1 protein expression (r = 0.7286, P < 0.01), and MVD of the PlexinA1 positive staining group (25.25 +/- 3.93) was significantly higher than that of the negative group (19.56 +/- 1.75), (P < 0.01). Proliferation index of tumor cells within tumor tissues were positively correlated with PlexinA1 mRNA expression (r = 0.5420, P = 0.014 < 0.01) and PlexinA1 protein expression (r = 0.5024, P = 0.024 < 0.05). The proliferation index of the PlexinA1 positive staining group (567.69 +/- 125.61) was significantly higher than that of the negative group (369.58 +/- 116.88), (P < 0.01).
CONCLUSION: PlexinA1 may play an important role in the occurrence and development of gastric carcinoma, and be related to tumor angiogenesis and proliferation.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18161927      PMCID: PMC4611296          DOI: 10.3748/wjg.v13.i48.6558

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  12 in total

Review 1.  Emerging roles for semaphorins in neural regeneration.

Authors:  R J Pasterkamp; J Verhaagen
Journal:  Brain Res Brain Res Rev       Date:  2001-03

2.  Dual roles of Sema6D in cardiac morphogenesis through region-specific association of its receptor, Plexin-A1, with off-track and vascular endothelial growth factor receptor type 2.

Authors:  Toshihiko Toyofuku; Hong Zhang; Atsushi Kumanogoh; Noriko Takegahara; Fumikazu Suto; Junko Kamei; Kazuhiro Aoki; Masanori Yabuki; Masatsugu Hori; Hajime Fujisawa; Hitoshi Kikutani
Journal:  Genes Dev       Date:  2004-02-20       Impact factor: 11.361

3.  Guidance of myocardial patterning in cardiac development by Sema6D reverse signalling.

Authors:  Toshihiko Toyofuku; Hong Zhang; Atsushi Kumanogoh; Noriko Takegahara; Masanori Yabuki; Koichiro Harada; Masatsugu Hori; Hitoshi Kikutani
Journal:  Nat Cell Biol       Date:  2004-11-14       Impact factor: 28.824

4.  The expression of plexins during mouse embryogenesis.

Authors:  Nina M Perälä; Tiina Immonen; Hannu Sariola
Journal:  Gene Expr Patterns       Date:  2005-02       Impact factor: 1.224

5.  Vascular endothelial growth factor is a secreted angiogenic mitogen.

Authors:  D W Leung; G Cachianes; W J Kuang; D V Goeddel; N Ferrara
Journal:  Science       Date:  1989-12-08       Impact factor: 47.728

6.  Vascular endothelial growth factor and angiopoietin in liver regeneration.

Authors:  Y Kraizer; N Mawasi; J Seagal; M Paizi; N Assy; G Spira
Journal:  Biochem Biophys Res Commun       Date:  2001-09-14       Impact factor: 3.575

7.  Plexin-A1 and its interaction with DAP12 in immune responses and bone homeostasis.

Authors:  Noriko Takegahara; Hyota Takamatsu; Toshihiko Toyofuku; Tohru Tsujimura; Tatsusada Okuno; Kazunori Yukawa; Masayuki Mizui; Midori Yamamoto; Durbaka V R Prasad; Kazuhiro Suzuki; Masaru Ishii; Kenta Terai; Masayuki Moriya; Yuji Nakatsuji; Saburo Sakoda; Shintaro Sato; Shizuo Akira; Kiyoshi Takeda; Masanori Inui; Toshiyuki Takai; Masahito Ikawa; Masaru Okabe; Atsushi Kumanogoh; Hitoshi Kikutani
Journal:  Nat Cell Biol       Date:  2006-05-21       Impact factor: 28.824

8.  Identification of high-risk patients by assessment of nuclear Ki-67 expression in a prospective study of endometrial carcinomas.

Authors:  H B Salvesen; O E Iversen; L A Akslen
Journal:  Clin Cancer Res       Date:  1998-11       Impact factor: 12.531

Review 9.  Tumorigenesis and the angiogenic switch.

Authors:  Gabriele Bergers; Laura E Benjamin
Journal:  Nat Rev Cancer       Date:  2003-06       Impact factor: 60.716

Review 10.  Angiogenesis in cancer, vascular, rheumatoid and other disease.

Authors:  J Folkman
Journal:  Nat Med       Date:  1995-01       Impact factor: 53.440

View more
  5 in total

1.  Expression of semaphorin 6D and its receptor plexin-A1 in gastric cancer and their association with tumor angiogenesis.

Authors:  Yanjie Lu; Qian Xu; Lei Chen; Yanzhen Zuo; Shaochen Liu; Yatao Hu; Xiaoru Li; Yuhong Li; Xiangyang Zhao
Journal:  Oncol Lett       Date:  2016-09-29       Impact factor: 2.967

Review 2.  Neuropilins: expression and roles in the epithelium.

Authors:  Jonathan R L Wild; Carolyn A Staton; Keith Chapple; Bernard M Corfe
Journal:  Int J Exp Pathol       Date:  2012-04       Impact factor: 1.925

3.  PlexinA1 activation induced by β2-AR promotes epithelial-mesenchymal transition through JAK-STAT3 signaling in human gastric cancer cells.

Authors:  Ying Liu; Yanhui Hao; Hanzheng Zhao; Ying Zhang; Die Cheng; Li Zhao; Yuqiao Peng; Yanjie Lu; Yuhong Li
Journal:  J Cancer       Date:  2022-04-18       Impact factor: 4.478

4.  Isoprenaline/β2-AR activates Plexin-A1/VEGFR2 signals via VEGF secretion in gastric cancer cells to promote tumor angiogenesis.

Authors:  Yanjie Lu; Qian Xu; Yanzhen Zuo; Lei Liu; Shaochen Liu; Lei Chen; Kang Wang; Yuntao Lei; Xiangyang Zhao; Yuhong Li
Journal:  BMC Cancer       Date:  2017-12-20       Impact factor: 4.430

5.  RNAi-mediated inhibition of Lgr5 leads to decreased angiogenesis in gastric cancer.

Authors:  Hong-Qing Xi; Ke-Cheng Zhang; Ji-Yang Li; Jian-Xin Cui; Yun-He Gao; Bo Wei; Dongsheng Huang; Lin Chen
Journal:  Oncotarget       Date:  2017-05-09
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.